Not Signed In - More European Patients With Epilepsy To Benefit From Keppra(reg)
Sat, 20 Jan 2007 03:00 PM EST
... The European Commission (EC) has approved Keppra(reg) (levetiracetam), as adjunctive therapy for the treatment of primary generalised tonic-clonic (PGTC) seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy (IGE). [click link for full article] ...
Related Topics
- Levetiracetam
- Epilepsy
- WISE EARS!® At Work!
- WISE EARS!® Campaign to Prevent NIHL
- WISE EARS!® Tips: Hearing Matters
- Black Alder
- Levetiracetam Oral Solution
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Pension
- European Goldenrod
- Atherosclerosis
- Most people with small tumors will have no permanent paralysis of the face after surgery. However, about two-thirds of patients with large tumors will have some permanent facial weakness after surgery.
- Turmeric
- Lecithin
- Coenzyme Q-10
- Vegetarianism
email this page
print this page
bookmark this page
feedback on this page
